Kathryn McNeil - Nanobiotix VP Relations

NANO Stock  EUR 5.45  0.04  0.73%   

Insider

Kathryn McNeil is VP Relations of Nanobiotix SA
Age 48
Phone33 1 40 26 04 70
Webhttps://www.nanobiotix.com

Nanobiotix Management Efficiency

The company has return on total asset (ROA) of (0.2916) % which means that it has lost $0.2916 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (1.9869) %, meaning that it generated substantial loss on money invested by shareholders. Nanobiotix's management efficiency ratios could be used to measure how well Nanobiotix manages its routine affairs as well as how well it operates its assets and liabilities.
The company has accumulated 35.56 M in total debt with debt to equity ratio (D/E) of 144.0, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Nanobiotix SA has a current ratio of 3.61, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist Nanobiotix until it has trouble settling it off, either with new capital or with free cash flow. So, Nanobiotix's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Nanobiotix SA sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Nanobiotix to invest in growth at high rates of return. When we think about Nanobiotix's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

INSIDER Age

Francois NicolasGuerbet S A
52
Michel TorrisBonduelle SCA
N/A
Celine BarralBonduelle SCA
N/A
Benoit BonduelleBonduelle SCA
N/A
Thomas BretteSocit BIC SA
N/A
Valrie BrissartGuerbet S A
N/A
Charlotte BamiereGuerbet S A
N/A
Daniel VielfaureBonduelle SCA
N/A
Jerome EstampesGuerbet S A
N/A
Chester TwiggSocit BIC SA
N/A
Ekaterina EliseevaBonduelle SCA
N/A
JeanFrancois BlancGuerbet S A
N/A
Frederic BesemeBiomerieux SA
67
Valerie LeyldeBiomerieux SA
N/A
Elizabeth MaulSocit BIC SA
N/A
Sarah DayreGuerbet S A
N/A
AnneLaure DelasalleGuerbet S A
N/A
Gregory SansonBonduelle SCA
N/A
Gianfranco DAmicoBonduelle SCA
N/A
Peter DalsbergSocit BIC SA
N/A
Charles MorganSocit BIC SA
N/A
Nanobiotix SA, a late stage clinical company, develops and sells nanomedicine for the treatment of cancer worldwide. Nanobiotix SA was incorporated in 2003 and is headquartered in Paris, France. NANOBIOTIX operates under Drug Manufacturers - Major classification in France and is traded on Paris Stock Exchange. It employs 102 people. Nanobiotix SA (NANO) is traded on Euronext Paris in France and employs 103 people.

Management Performance

Nanobiotix SA Leadership Team

Elected by the shareholders, the Nanobiotix's board of directors comprises two types of representatives: Nanobiotix inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Nanobiotix. The board's role is to monitor Nanobiotix's management team and ensure that shareholders' interests are well served. Nanobiotix's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Nanobiotix's outside directors are responsible for providing unbiased perspectives on the board's policies.
Sarah Gaubert, Head Department
Elsa Borghi, Head Discovery
Brandon Owens, VP Communication
Earl Bergey, CoFounder
Kathryn McNeil, VP Relations
AnneJuliette MA, Chief Board
Bart Rhijn, CFO Board
Pr Prasad, CoFounder Board
Alain Dostie, Chief Officer
Laurent Levy, Pres CoFounder

Nanobiotix Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Nanobiotix a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Nanobiotix in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Nanobiotix's short interest history, or implied volatility extrapolated from Nanobiotix options trading.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nanobiotix SA. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors.
For information on how to trade Nanobiotix Stock refer to our How to Trade Nanobiotix Stock guide.
You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.

Complementary Tools for Nanobiotix Stock analysis

When running Nanobiotix's price analysis, check to measure Nanobiotix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nanobiotix is operating at the current time. Most of Nanobiotix's value examination focuses on studying past and present price action to predict the probability of Nanobiotix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nanobiotix's price. Additionally, you may evaluate how the addition of Nanobiotix to your portfolios can decrease your overall portfolio volatility.
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Equity Valuation
Check real value of public entities based on technical and fundamental data
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Bonds Directory
Find actively traded corporate debentures issued by US companies
Please note, there is a significant difference between Nanobiotix's value and its price as these two are different measures arrived at by different means. Investors typically determine if Nanobiotix is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Nanobiotix's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.